🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to measure the efficacy and safety of rilvegos...
Status
Recruiting
Location
Research Site
Start Date
2025-12-04
Trial ID
NCT07221253
Treatments Being Tested
DESTINY-Gastric03 will investigate the safety, tolerability, pharmacokineti...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-06-03
Trial ID
NCT04379596
DESTINY-Lung03 will investigate the safety and tolerability of trastuzumab ...
Status
Recruiting
Location
Research Site
Start Date
2021-03-09
Trial ID
NCT04686305
Treatments Being Tested
The purpose of this study is to determine the subcutaneous (SC) dose that g...
Status
Recruiting
Location
Research Site
Start Date
2025-11-25
Trial ID
NCT07161414
Treatments Being Tested
The purpose of this study is to further advance the ability to practice per...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2010-03-01
Trial ID
NCT01042379
Treatments Being Tested
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + r...
Status
Recruiting
Location
Research Site
Start Date
2025-03-27
Trial ID
NCT06989112
Treatments Being Tested
GEMINI-PeriOp GC study will assess the safety, tolerability, pharmacokineti...
Status
Recruiting
Location
Research Site
Start Date
2025-07-17
Trial ID
NCT07069712
This is a Phase III, randomised, open-label, sponsor-blinded, 3-arm, multic...
Status
Recruiting
Location
Research Site
Start Date
2025-05-06
Trial ID
NCT06921785
Treatments Being Tested
Purpose: to assess efficacy and safety of Dato-DXd + rilvegostomig as adjuv...
Status
Recruiting
Location
Research Site
Start Date
2026-07-16
Trial ID
NCT07720284
Treatments Being Tested
A global study to assess the efficacy and tolerability of rilvegostomig com...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-12-04
Trial ID
NCT06109779
Treatments Being Tested